Mangoceuticals Common Stock Stock Price Prediction
| MGRX Stock | 0.78 0.21 21.21% |
Momentum 33
Sell Stretched
Oversold | Overbought |
Quarterly Revenue Growth (0.37) |
Using Mangoceuticals Common hype-based prediction, you can estimate the value of Mangoceuticals Common Stock from the perspective of Mangoceuticals Common response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Mangoceuticals Common to buy its stock at a price that has no basis in reality. In that case, they are not buying Mangoceuticals because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Mangoceuticals Common after-hype prediction price | USD 0.77 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Mangoceuticals | Build AI portfolio with Mangoceuticals Stock |
Mangoceuticals Common After-Hype Price Prediction Density Analysis
As far as predicting the price of Mangoceuticals Common at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mangoceuticals Common or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Mangoceuticals Common, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Mangoceuticals Common Estimiated After-Hype Price Volatility
In the context of predicting Mangoceuticals Common's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mangoceuticals Common's historical news coverage. Mangoceuticals Common's after-hype downside and upside margins for the prediction period are 0.04 and 11.77, respectively. We have considered Mangoceuticals Common's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Mangoceuticals Common is out of control at this time. Analysis and calculation of next after-hype price of Mangoceuticals Common is based on 3 months time horizon.
Mangoceuticals Common Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Mangoceuticals Common is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mangoceuticals Common backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mangoceuticals Common, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.19 | 11.00 | 0.01 | 0.31 | 25 Events / Month | 6 Events / Month | In about 25 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.78 | 0.77 | 1.28 |
|
Mangoceuticals Common Hype Timeline
Mangoceuticals Common is now traded for 0.78. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.31. Mangoceuticals is projected to decline in value after the next headline, with the price expected to drop to 0.77. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.28%, whereas the daily expected return is now at -1.19%. The volatility of related hype on Mangoceuticals Common is about 4230.61%, with the expected price after the next announcement by competition of 0.47. About 26.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.76. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mangoceuticals Common recorded a loss per share of 2.72. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 16th of October 2024. Given the investment horizon of 90 days the next projected press release will be in about 25 days. Check out Mangoceuticals Common Basic Forecasting Models to cross-verify your projections.Mangoceuticals Common Related Hype Analysis
Having access to credible news sources related to Mangoceuticals Common's direct competition is more important than ever and may enhance your ability to predict Mangoceuticals Common's future price movements. Getting to know how Mangoceuticals Common's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mangoceuticals Common may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| VSEE | VSee Health | (0.03) | 11 per month | 7.67 | 0.02 | 13.51 | (13.33) | 120.19 | |
| FEMY | Femasys | 0.15 | 7 per month | 8.17 | 0.0008 | 15.00 | (13.54) | 50.65 | |
| CASI | CASI Pharmaceuticals | (0.60) | 2 per month | 0.00 | (0.14) | 9.14 | (7.61) | 20.42 | |
| ENTO | Entero Therapeutics | (0.60) | 2 per month | 7.81 | 0.07 | 16.50 | (17.06) | 56.75 | |
| HCTI | Healthcare Triangle | (0.06) | 10 per month | 0.00 | (0.26) | 11.89 | (17.35) | 52.31 | |
| CLSD | Clearside Biomedical | 0.36 | 6 per month | 0.00 | (0.27) | 7.96 | (17.54) | 83.67 | |
| TOI | Oncology Institute | (1.28) | 10 per month | 4.98 | 0.03 | 6.81 | (6.85) | 42.16 | |
| PALI | Palisade Bio | (0.08) | 7 per month | 6.69 | 0.02 | 14.44 | (11.37) | 35.05 | |
| ASBP | Aspire BioPharma | (0.01) | 7 per month | 0.00 | (0.14) | 18.18 | (20.00) | 63.21 | |
| CING | Cingulate | (0.45) | 8 per month | 3.89 | 0.08 | 6.22 | (5.52) | 20.19 |
Mangoceuticals Common Additional Predictive Modules
Most predictive techniques to examine Mangoceuticals price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mangoceuticals using various technical indicators. When you analyze Mangoceuticals charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Mangoceuticals Common Predictive Indicators
The successful prediction of Mangoceuticals Common stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Mangoceuticals Common Stock, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Mangoceuticals Common based on analysis of Mangoceuticals Common hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Mangoceuticals Common's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Mangoceuticals Common's related companies. | 2025 | 2026 (projected) | Dividend Yield | 0.15 | 0.14 | Price To Sales Ratio | 8.94 | 8.5 |
Story Coverage note for Mangoceuticals Common
The number of cover stories for Mangoceuticals Common depends on current market conditions and Mangoceuticals Common's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mangoceuticals Common is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mangoceuticals Common's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Mangoceuticals Common Short Properties
Mangoceuticals Common's future price predictability will typically decrease when Mangoceuticals Common's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Mangoceuticals Common Stock often depends not only on the future outlook of the potential Mangoceuticals Common's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mangoceuticals Common's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2 M | |
| Cash And Short Term Investments | 58.7 K |
Additional Tools for Mangoceuticals Stock Analysis
When running Mangoceuticals Common's price analysis, check to measure Mangoceuticals Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals Common is operating at the current time. Most of Mangoceuticals Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals Common's price. Additionally, you may evaluate how the addition of Mangoceuticals Common to your portfolios can decrease your overall portfolio volatility.